Slovakia SUKL

Evrysdi (risdiplam) 0.75 mg/ml powder for oral solution – Direct Healthcare Professional Communication

Original title: Evrysdi (risdiplam) 0,75 mg/ml prášok na perorálny roztok

Direct Healthcare Professional Communication issued for Evrysdi (risdiplam) 0.75 mg/ml regarding new important safety, efficacy or use information.

Low obligation Product class Pharmaceuticals Slovakia Pharmacovigilance

DHPC (Direct Healthcare Professional Communication) predstavuje priamu komunikáciu zdravotníckym pracovníkom, prostredníctvom ktorej sú poskytované nové dôležité informácie týkajúce sa bezpečnosti, účinnosti alebo správneho používania lieku.

Read the official source ↗

Published by Slovakia SUKL. HealthSignal links to the original document; the summary above is extracted from the source text.